206 related articles for article (PubMed ID: 14973368)
1. Generation of receptor-active, globotriaosyl ceramide/cholesterol lipid 'rafts' in vitro : A new assay to define factors affecting glycosphingolipid receptor activity.
Nutikka A; Lingwood C
Glycoconj J; 2004; 20(1):33-8. PubMed ID: 14973368
[TBL] [Abstract][Full Text] [Related]
2. Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues.
Kiarash A; Boyd B; Lingwood CA
J Biol Chem; 1994 Apr; 269(15):11138-46. PubMed ID: 8157640
[TBL] [Abstract][Full Text] [Related]
3. Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies.
Tam P; Mahfoud R; Nutikka A; Khine AA; Binnington B; Paroutis P; Lingwood C
J Cell Physiol; 2008 Sep; 216(3):750-63. PubMed ID: 18446787
[TBL] [Abstract][Full Text] [Related]
4. Localization of the binding site for modified Gb3 on verotoxin 1 using fluorescence analysis.
Picking WD; McCann JA; Nutikka A; Lingwood CA
Biochemistry; 1999 Jun; 38(22):7177-84. PubMed ID: 10353828
[TBL] [Abstract][Full Text] [Related]
5. A major fraction of glycosphingolipids in model and cellular cholesterol-containing membranes is undetectable by their binding proteins.
Mahfoud R; Manis A; Binnington B; Ackerley C; Lingwood CA
J Biol Chem; 2010 Nov; 285(46):36049-59. PubMed ID: 20716521
[TBL] [Abstract][Full Text] [Related]
6. Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs.
Boyd B; Tyrrell G; Maloney M; Gyles C; Brunton J; Lingwood C
J Exp Med; 1993 Jun; 177(6):1745-53. PubMed ID: 8496689
[TBL] [Abstract][Full Text] [Related]
7. Shiga toxin glycosphingolipid receptors and their lipid membrane ensemble in primary human blood-brain barrier endothelial cells.
Legros N; Dusny S; Humpf HU; Pohlentz G; Karch H; Müthing J
Glycobiology; 2017 Jan; 27(1):99-109. PubMed ID: 27558838
[TBL] [Abstract][Full Text] [Related]
8. Different binding property of verotoxin-1 and verotoxin-2 against their glycolipid receptor, globotriaosylceramide.
Itoh K; Tezuka T; Inoue K; Tada H; Suzuki T
Tohoku J Exp Med; 2001 Dec; 195(4):237-43. PubMed ID: 11908825
[TBL] [Abstract][Full Text] [Related]
9. New aspects of the regulation of glycosphingolipid receptor function.
Lingwood CA; Manis A; Mahfoud R; Khan F; Binnington B; Mylvaganam M
Chem Phys Lipids; 2010 Jan; 163(1):27-35. PubMed ID: 19781539
[TBL] [Abstract][Full Text] [Related]
10. Effect of globotriaosyl ceramide fatty acid alpha-hydroxylation on the binding by verotoxin 1 and verotoxin 2.
Binnington B; Lingwood D; Nutikka A; Lingwood CA
Neurochem Res; 2002 Aug; 27(7-8):807-13. PubMed ID: 12374217
[TBL] [Abstract][Full Text] [Related]
11. Adamantyl globotriaosyl ceramide: a monovalent soluble mimic which inhibits verotoxin binding to its glycolipid receptor.
Mylvaganam M; Lingwood CA
Biochem Biophys Res Commun; 1999 Apr; 257(2):391-4. PubMed ID: 10198223
[TBL] [Abstract][Full Text] [Related]
12. The identification of three biologically relevant globotriaosyl ceramide receptor binding sites on the Verotoxin 1 B subunit.
Bast DJ; Banerjee L; Clark C; Read RJ; Brunton JL
Mol Microbiol; 1999 Jun; 32(5):953-60. PubMed ID: 10361298
[TBL] [Abstract][Full Text] [Related]
13. Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains.
Betz J; Bielaszewska M; Thies A; Humpf HU; Dreisewerd K; Karch H; Kim KS; Friedrich AW; Müthing J
J Lipid Res; 2011 Apr; 52(4):618-34. PubMed ID: 21252262
[TBL] [Abstract][Full Text] [Related]
14. Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a supported bilayer film and liposomes.
Arab S; Lingwood CA
Glycoconj J; 1996 Apr; 13(2):159-66. PubMed ID: 8737240
[TBL] [Abstract][Full Text] [Related]
15. Shiga toxin glycosphingolipid receptors of Vero-B4 kidney epithelial cells and their membrane microdomain lipid environment.
Steil D; Schepers CL; Pohlentz G; Legros N; Runde J; Humpf HU; Karch H; Müthing J
J Lipid Res; 2015 Dec; 56(12):2322-36. PubMed ID: 26464281
[TBL] [Abstract][Full Text] [Related]
16. Treatment of neutral glycosphingolipid lysosomal storage diseases via inhibition of the ABC drug transporter, MDR1. Cyclosporin A can lower serum and liver globotriaosyl ceramide levels in the Fabry mouse model.
Mattocks M; Bagovich M; De Rosa M; Bond S; Binnington B; Rasaiah VI; Medin J; Lingwood C
FEBS J; 2006 May; 273(9):2064-75. PubMed ID: 16724420
[TBL] [Abstract][Full Text] [Related]
17. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
Khine AA; Lingwood CA
J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
[TBL] [Abstract][Full Text] [Related]
18. Brefeldin A and filipin distinguish two globotriaosyl ceramide/verotoxin-1 intracellular trafficking pathways involved in Vero cell cytotoxicity.
Khine AA; Tam P; Nutikka A; Lingwood CA
Glycobiology; 2004 Aug; 14(8):701-12. PubMed ID: 15102715
[TBL] [Abstract][Full Text] [Related]
19. Functionally different pools of Shiga toxin receptor, globotriaosyl ceramide, in HeLa cells.
Falguières T; Römer W; Amessou M; Afonso C; Wolf C; Tabet JC; Lamaze C; Johannes L
FEBS J; 2006 Nov; 273(22):5205-18. PubMed ID: 17059464
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid-dependent globotriaosyl ceramide receptor function in detergent resistant model membranes.
Mahfoud R; Manis A; Lingwood CA
J Lipid Res; 2009 Sep; 50(9):1744-55. PubMed ID: 18716315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]